Drug Nanocrystals: A Comprehensive Review with Current Regulatory Guidelines

被引:28
作者
Dhaval, Mori [1 ]
Makwana, Jalpa [1 ]
Sakariya, Ekta [1 ]
Dudhat, Kiran [2 ]
机构
[1] BK Mody Govt Pharm Coll, Rajkot 360005, Gujarat, India
[2] KV Virani Inst Pharm & Res Ctr, Badhada, Gujarat, India
关键词
Drug nanocrystals; manufacturing methods; physical and chemical stability; regulatory guideline; marketed products; bioavailability; POORLY SOLUBLE DRUGS; FORMULATION DEVELOPMENT; UNDERLYING MECHANISMS; ORAL BIOAVAILABILITY; PARENTERAL DELIVERY; DISSOLUTION RATE; NANOSUSPENSION; ENHANCEMENT; TECHNOLOGY; SOLUBILITY;
D O I
10.2174/1567201817666200512104833
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug nanocrystals offer an attractive approach for improving the solubility and dissolution rate of poorly soluble drugs which accounts for nearly 40 % newly discovered drug molecules. Both methods for manufacturing drug nanocrystals have high industrial acceptability for being simple and easy to scale which is evident from the number of approved products available in the market. Ability to modify multiple aspects of dosage form like bioavailability, release pattern and dosage form requirement along with flexibility in choosing final dosage form starting from the tablet, capsule, suspension to parenteral one, have made nanocrystal technology one of the very promising and adaptable technology for dosage form design.
引用
收藏
页码:470 / 482
页数:13
相关论文
共 88 条
[1]  
Ahmad S., 2015, INT J SCI RES, V4, P367
[2]   Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation [J].
Al Shaal, Loaye ;
Shegokar, Ranjita ;
Mueller, Rainer H. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 420 (01) :133-140
[3]   Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling [J].
Ali, Hany S. M. ;
York, Peter ;
Ali, Ahmed M. A. ;
Blagden, Nicholas .
JOURNAL OF CONTROLLED RELEASE, 2011, 149 (02) :175-181
[4]  
[Anonymous], NANOPARTICLE TECHNOL
[5]  
[Anonymous], 2007, Nanoparticulate drug delivery systems, DOI [DOI 10.1201/9781420008449, 10.1201/9781420008449]
[6]  
[Anonymous], 2003, NewDrugs
[7]  
AOYAGI N, 1982, J PHARMACOBIO-DYNAM, V5, P120
[8]   Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound [J].
Baka, Edit ;
Comer, John E. A. ;
Takacs-Novak, Krisztina .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 46 (02) :335-341
[9]   Solubility: it's not just for physical chemists [J].
Bhattachar, Shobha N. ;
Deschenes, Laura A. ;
Wesley, James A. .
DRUG DISCOVERY TODAY, 2006, 11 (21-22) :1012-1018
[10]   DLS and zeta potential - What they are and what they are not? [J].
Bhattacharjee, Sourav .
JOURNAL OF CONTROLLED RELEASE, 2016, 235 :337-351